P. Pautier

500 total citations
27 papers, 325 citations indexed

About

P. Pautier is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, P. Pautier has authored 27 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Reproductive Medicine, 11 papers in Obstetrics and Gynecology and 10 papers in Oncology. Recurrent topics in P. Pautier's work include Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Uterine Myomas and Treatments (6 papers). P. Pautier is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Endometrial and Cervical Cancer Treatments (8 papers) and Uterine Myomas and Treatments (6 papers). P. Pautier collaborates with scholars based in France, Belgium and Lebanon. P. Pautier's co-authors include Philippe Morice, Pierre Duvillard, C. Lhommé, Damienne Castaigne, David Atallah, A. Rey, Catherine Genestie, Agustín Rodríguez, A. Thoury and S. Camatte and has published in prestigious journals such as Journal of Clinical Oncology, Human Reproduction and European Journal of Cancer.

In The Last Decade

P. Pautier

25 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Pautier France 9 165 161 79 73 55 27 325
Ali Yavuzcan Türkiye 12 210 1.3× 142 0.9× 91 1.2× 68 0.9× 23 0.4× 48 389
Javier De Santiago Spain 12 284 1.7× 237 1.5× 59 0.7× 122 1.7× 34 0.6× 36 415
Stefania Perotto Italy 11 162 1.0× 178 1.1× 80 1.0× 103 1.4× 32 0.6× 22 331
Micaela Petrone Italy 11 84 0.5× 120 0.7× 96 1.2× 66 0.9× 33 0.6× 32 324
Eun Young Ki South Korea 12 138 0.8× 111 0.7× 122 1.5× 171 2.3× 46 0.8× 29 414
Luis Sanfrutos Spain 11 307 1.9× 159 1.0× 72 0.9× 44 0.6× 47 0.9× 21 562
Masaki Kamio Japan 12 246 1.5× 152 0.9× 49 0.6× 84 1.2× 42 0.8× 44 349
M Moukhtar United States 13 201 1.2× 231 1.4× 63 0.8× 92 1.3× 30 0.5× 18 392
Ioannis Biliatis United Kingdom 13 331 2.0× 268 1.7× 84 1.1× 86 1.2× 23 0.4× 29 519
Lua Eiriksson Canada 11 132 0.8× 101 0.6× 84 1.1× 102 1.4× 20 0.4× 33 360

Countries citing papers authored by P. Pautier

Since Specialization
Citations

This map shows the geographic impact of P. Pautier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Pautier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Pautier more than expected).

Fields of papers citing papers by P. Pautier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Pautier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Pautier. The network helps show where P. Pautier may publish in the future.

Co-authorship network of co-authors of P. Pautier

This figure shows the co-authorship network connecting the top 25 collaborators of P. Pautier. A scholar is included among the top collaborators of P. Pautier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Pautier. P. Pautier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grellard, Jean‐Michel, Elsa Kalbacher, Olivier Trédan, et al.. (2024). Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study. Gynecologic Oncology. 187. 139–144. 3 indexed citations
3.
Maulard, Amandine, Catherine Genestie, P. Pautier, et al.. (2019). EP665 Juvenile granulosa cell tumors of the ovary: a retrospective study of 36 patients. A385.2–A385. 1 indexed citations
4.
Pautier, P., Mojgan Devouassoux‐Shisheboran, Isabelle Treilleux, et al.. (2015). 2705 The French National Network dedicated to Ovarian Malignant Rare Tumors (TMRO): How this organization changed management over the time for rare cancers. European Journal of Cancer. 51. S533–S533. 1 indexed citations
5.
Koskas, Martin, Catherine Uzan, Sébastien Gouy, et al.. (2011). Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma). Human Reproduction. 26(4). 808–814. 24 indexed citations
6.
Pautier, P., Anne Floquet, Laurence Gladieff, et al.. (2011). A Randomized Clinical Trial of Adjuvant Chemotherapy with Doxorubicin, Ifosfamide, and Cisplatin in Localized Uterine Sarcomas. Results On 81 Randomized Patients. European Journal of Cancer. 47. 15–15. 1 indexed citations
7.
Pautier, P., Anne Floquet, Laurence Gladieff, et al.. (2011). A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin in localized uterine sarcomas: Results from 81 randomized patients.. Journal of Clinical Oncology. 29(15_suppl). 10022–10022. 3 indexed citations
8.
Rouge, T. De La Motte, Judith Michels, Caroline Even, et al.. (2009). Nouvelles molécules et thérapeutiques moléculaires ciblées dans les adénocarcinomes ovariens de stades avancés. Bulletin du Cancer. 96(12). 1215–1224. 5 indexed citations
9.
Uzan, Catherine, Sébastien Gouy, P. Pautier, et al.. (2009). La paramétrectomie est-elle nécessaire pour tous les cancers du col à un stade précoce ?. Gynécologie Obstétrique & Fertilité. 37(6). 504–509. 2 indexed citations
10.
Duvillard, Pierre, Agustín Sánchez Rey, Philippe Morice, et al.. (2008). Clinical features, recurrence patterns, and treatment in endometrial stromal sarcomas: A 30-year, single-institution experience. Journal of Clinical Oncology. 26(15_suppl). 10574–10574. 1 indexed citations
11.
Haie-Méder, Christine, C. Lhommé, P. Pautier, et al.. (2007). Chemoradiation therapy in pregnant patients treated for advanced-stage cervical carcinoma during the first trimester of pregnancy: report of two cases. International Journal of Gynecological Cancer. 17(1). 270–274. 21 indexed citations
13.
Atallah, David, Philippe Morice, S. Camatte, et al.. (2004). Place et résultats de l'examen extemporané dans la stratégie chirurgicale des tumeurs épithéliales malignes et à la limite de la malignité de l'ovaire. Gynécologie Obstétrique & Fertilité. 32(7-8). 651–656. 2 indexed citations
14.
Morice, Philippe, S. Camatte, É. Fondrinier, et al.. (2002). [What hysterectomy procedure should be carried out for cancer of the endometrium in stage I-II].. PubMed. 89(2). 157–9. 1 indexed citations
15.
Morice, Philippe, S. Camatte, P. Pautier, et al.. (2001). Conservative treatment of ovarian borderline tumor. European Journal of Cancer. 37. S276–S276.
16.
Faivre, Sandrine, Éric Raymond, François Lokiec, et al.. (2001). Phase I–II and pharmacokinetic study combining gemcitabine (GEM) with oxaliplatin (OX) in patients (pts) with advanced non-small-cell lung (NSCLC) and ovarian carcinoma (OC). European Journal of Cancer. 37. S70–S70. 8 indexed citations
17.
Morice, Philippe, Aurélie Fabre, P. Pautier, et al.. (2000). Krukenberg tumor: a clinico-pathological study of 15 cases.. PubMed. 20(3). 202–6. 20 indexed citations
18.
Morice, Philippe, et al.. (2000). Isolated para-aortic node involvement in stage IB/II cervical carcinoma.. PubMed. 21(2). 123–5. 13 indexed citations
19.
Morice, Philippe, Damienne Castaigne, P. Pautier, et al.. (1999). Frozen section of lymph nodes in uterine cervical carcinoma.. PubMed. 47(5). 223–6. 7 indexed citations
20.
Mounier, Nicolas, Dominique Cazals, P. Pautier, et al.. (1996). EBV reactivation associated with Hodgkin's disease relapse and fatal hemophagocytic syndrome.. PubMed. 10(11). 1848–1848. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026